Efficacy of ε-aminocaproic acid in children undergoing cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 3, 1999, Pages 304-308

  Williams, Glyn D ^a,b   Bratton, Susan L ^a   Riley, Elizabeth C ^a   Ramamoorthy, Chandra ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Antifibrinolytic agents; Blood transfusion; Cardiopulmonary bypass; Congenital heart surgery; aminocaproic acid

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; HEPARIN;

ARTICLE; BLEEDING; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEMODILUTION; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PEDIATRIC SURGERY; PRIORITY JOURNAL; ADOLESCENT; ADULT; BLOOD CLOTTING; CASE CONTROL STUDY; CHILD; HEART SURGERY; INFANT; PRESCHOOL CHILD; PROSPECTIVE STUDY;

6-AMINOCAPROIC ACID; ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES;

EID: 0032587135     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90268-9     Document Type: Article

References (25)

1. Chan AK, Leaker M, Burrows FA, et al: Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 77:270-277, 1997
2. Kern FH, Morana NJ, Sears JJ, Hickey PR: Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 54:541-546, 1992
3. Manno CS, Hedberg KW, Kim HC, et al: Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open-heart surgery in children. Blood 77:930-936, 1991
4. Petaja J, Lundstrom U, Leijala M, et al: Bleeding and the use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 109:524-529, 1995
5. Hardy JF, Belisle S: Natural and synthetic antifibrinolytics: Inert, poisonous or therapeutic agents? Can J Anaesth 44:913-917, 1997
6. Slaughter TF, Faghih F, Greenberg CS, et al: The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 85:1221-1226, 1997
7. DelRossi AJ, Cernaianu AC, Botros S, et al: Prophylactic treatment of postperfusion bleeding using EACA. Chest 96:27-30, 1989
8. Karski JM, Teasdale SJ, Norman PH, et al: Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid. J Cardiothorac Vasc Anesth 7:431-435, 1993
9. Jordan D, Delphin E, Rose E: Prophylactic epsilon-aminocaproic acid (EACA) administration minimizes blood replacement therapy during cardiac surgery. Anesth Analg 80:827-829, 1995
10. Daily PO, Lamphere JA, Dembitsky WP, et al: Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirement in patients undergoing first-time coronary artery bypass grafting. J Thorac Cardiovasc Surg 108:99-108, 1994
11. Arom KV, Emery RW: Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg 57:1108-1112, 1994
12. Fremes SE, Wong BI, Lee E, et al: Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 58:1580-1588, 1994
13. Landymore RW, Murphy JT, Lummis H, Carter C: The use of low-dose aprotinin, epsilon-aminocaproic acid or tranexamic acid for prevention of mediastinal bleeding in patients receiving aspirin before coronary artery bypass operations. Eur J Cardiothorac Surg 11:798-800, 1997
14. McClure PD, Izsak J: The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology 40:604-608, 1974
15. Gans H, Krivit W: Problems in hemostasis during open-heart surgery. III. Epsilon aminocaproic acid as an inhibitor of plasminogen activator activity. Ann Surg 155:268-276, 1962
16. Sterns LP, Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: An analysis of 340 patients. Can J Surg 10:304-307, 1967
17. Spiess BD, Wall MH, Gillies BS, et al: A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass. Thromb Haemost 78:820-826, 1997
18. Guay J, Rivard GE: Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 62:1955-1960, 1996
19. Vander Salm TJ, Kaur S, Lancey RA, et al: Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg 112:1098-1107, 1996
20. Slaughter TF, Greenberg CS: Antifibrinolytic drugs and perioperative hemostasis. Am J Hematol 56:32-36, 1997
21. Pagliaro LA, Levin RH: Problems in Pediatric Drug Therapy. Hamilton, IL, Drug Intell, 1979
22. Bennett-Guerrero E, Sorohan JG, Canada AT, et al: Epsilon-aminocaproic acid plasma levels during cardiopulmonary bypass. Anesth Analg 85:248-251, 1997
23. Reid RW, Zimmerman AA, Laussen PC, et al: The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 84:990-996, 1997
24. Williams GD, Bratton SL, Riley EC, Ramamoorthy C: Association between age and blood loss in children undergoing open-heart surgery. Ann Thorac Surg 66:870-876, 1998
25. Miller BE, Mochizuki T, Levy JH, et al: Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 85:1196-1202, 1997